Methicillin-resistant Staphylococcus aureus resistance to non-beta-lactam antimicrobials in the United States from 1996 to 2008

Diagnostic Microbiology and Infectious Disease
Jose BordonJulio Ramirez

Abstract

We report the resistance rates of Staphylococcus aureus to non-beta-lactam antimicrobials from The Surveillance Network Database-USA (Eurofins-Medinet, Chantilly, VA). Specimens studied were from lower respiratory tract, wounds, and blood. Patients were stratified by age group and patient setting. There were 2,053,219 isolates of S. aureus and 973,116 of methicillin-resistant S. aureus (MRSA). The MRSA rate increased until 2004 and then leveled off. MRSA showed decreasing resistance to tetracycline and trimethoprim-sulfamethoxazole (TMP-SMX). By age group, the greatest MRSA rate increase was for individuals 17 years and younger. Non-beta-lactam antimicrobials and particularly TMP-SMX should be considered therapeutic options for staphylococcal infections.

References

Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D F SahmG Piazza
Dec 11, 2003·JAMA : the Journal of the American Medical Association·Timothy S NaimiRuth Lynfield
Mar 5, 2005·The American Journal of Medicine·Jeffrey A LinderRandall S Stafford
Nov 1, 2006·Emerging Infectious Diseases·Louiselle LeBlancMarie-Eve Alary
Mar 1, 2007·Emerging Infectious Diseases·R Monina KlevensUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Oct 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary A NoskinMurtuza Bharmal

❮ Previous
Next ❯

Citations

Feb 27, 2013·Natural Product Research·Giovanni Gontijo de SouzaJacqueline Aparecida Takahashi
Apr 23, 2013·The Journal of Antimicrobial Chemotherapy·James A KarlowskyUNKNOWN Canadian Antimicrobial Resistance Alliance
Aug 23, 2011·Biosensors & Bioelectronics·Hatice Ceylan KoydemirGülşen Hasçelik
Dec 17, 2014·Expert Opinion on Pharmacotherapy·Abrar K ThabitDavid P Nicolau
May 23, 2015·Frontiers in Microbiology·Vicenta Cázares-DomínguezJuan Xicohtencatl-Cortes
Oct 9, 2014·Diagnostic Microbiology and Infectious Disease·J A KarlowskyG G Zhanel
Nov 23, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hassan NamdariMichael J Dowzicky
Apr 9, 2013·Revista Da Sociedade Brasileira De Medicina Tropical·Carolina Bioni Garcia TelesLuís Marcelo Aranha Camargo
Feb 6, 2017·Critical Care Nursing Clinics of North America·Jean E CefaluAlison H Davis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

JAMA : the Journal of the American Medical Association
Alexander J KallenActive Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Helen W BoucherJohn Bartlett
© 2021 Meta ULC. All rights reserved